All videos

New Malaria Vaccine Developed At Oxford

Oxford scientists have developed a ‘world-changing’ malaria vaccine. It can be made for a few dollars a dose, say experts, and offers up to 80% protection against malaria after 4 doses. The Oxford team say their R21 malaria vaccine is cheap, effective and easy to make. They’ve already struck a deal with the Serum Institute of India to manufacture 200 million doses a year, and it could be ready by 2023. Watch to learn more about this malaria vaccine.

Topics:
Health and Healthcare Systems
Share:
World Economic Forum logo

Forum Stories newsletter

Bringing you weekly curated insights and analysis on the global issues that matter.

Subscribe today

More on Health and Healthcare Systems
See all

How we rebalance the health data economy for shared value

Michael Byczkowski and Andy Moose

September 18, 2026

3:49

Research funding is one of the 'greatest inventions' say Nobel scientists

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2026 World Economic Forum